Funding
Turn ideas into impact
Show Me
Due: January 7, 2027
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-221
Due: January 7, 2027
Cancer Research Education Grants Program – Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
US $150,000
Type
Grant
Source
Federal
Opp Number
PAR-23-278
Due: January 7, 2027
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-167
Due: January 7, 2027
Cancer Research Education Grants Program – Research Experiences (R25 Clinical Trial Not Allowed)
US $300,000
Type
Grant
Source
Federal
Opp Number
PAR-23-277
Due: January 7, 2027
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-032
Due: January 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-069
Due: January 7, 2027
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-256
Due: January 7, 2027
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 – Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-377
Due: January 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-070
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?